Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Provident Financial
PROV
$111M
| $653K | ﹤0.01% |
38,253
+5,408
| +16% | +$92.7K |
|
|
YARW
3902
Yarrow Bioscience, Inc. Common Stock
YARW
$116M
| $653K | ﹤0.01% |
523
+5
| +1% | +$9.7K |
|
3903
Climb Global Solutions
CLMB
$527M
| $652K | ﹤0.01% |
96,844
+7,568
| +8% | +$51.4K |
|
|
NMRD
3904
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $650K | ﹤0.01% |
108,215
+23,593
| +28% | +$170K |
|
|
PLM
3905
DELISTED
PolyMet Mining Corp.
PLM
| $649K | ﹤0.01% |
213,071
+217
| +0.1% | +$723 |
|
3906
Lightpath Technologies
LPTH
$830M
| $647K | ﹤0.01% |
303,772
+120,870
| +66% | +$267K |
|
|
ZSAN
3907
DELISTED
Zosano Pharma Corporation
ZSAN
| $647K | ﹤0.01% |
25,723
+376
| +1% | +$9.75K |
|
|
HMPT
3908
DELISTED
Home Point Capital, Inc Common Stock
HMPT
| $644K | ﹤0.01% |
156,400
-8,742
| -5% | -$40.3K |
|
3909
Pangaea Logistics
PANL
$494M
| $643K | ﹤0.01% |
127,488
+19,514
| +18% | +$95.7K |
|
|
KVSA
3910
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $643K | ﹤0.01% |
65,183
| – | – |
|
3911
Forum Energy Technologies
FET
$942M
| $642K | ﹤0.01% |
28,521
-5,358
| -16% | -$110K |
|
3912
Immatics
IMTX
$1.32B
| $642K | ﹤0.01% |
49,448
+3,155
| +7% | +$40.1K |
|
|
LHDX
3913
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $639K | ﹤0.01% |
84,087
-10,586
| -11% | -$89.3K |
|
3914
Koss Corp
KOSS
$34.8M
| $638K | ﹤0.01% |
39,032
+2,938
| +8% | +$54.2K |
|
3915
Lantern Pharma
LTRN
$33.9M
| $637K | ﹤0.01% |
57,043
+1,564
| +3% | +$20.2K |
|
3916
Core Molding Technologies
CMT
$231M
| $635K | ﹤0.01% |
55,200
+5,568
| +11% | +$78.5K |
|
3917
AbCellera Biologics
ABCL
$3.33B
| $634K | ﹤0.01% |
31,664
-167,074
| -84% | -$2.95M |
|
|
LOGC
3918
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $634K | ﹤0.01% |
138,465
+6,344
| +5% | +$27.9K |
|
3919
Fuel Tech
FTEK
$46.2M
| $633K | ﹤0.01% |
363,880
+7,782
| +2% | +$14.7K |
|
3920
Comstock Holding Companies
CHCI
$180M
| $632K | ﹤0.01% |
132,209
+5,457
| +4% | +$30.9K |
|
3921
Consumer Portfolio Services
CPSS
$208M
| $630K | ﹤0.01% |
107,764
-1,075
| -1% | -$5.67K |
|
3922
LENSAR
LNSR
$99M
| $627K | ﹤0.01% |
79,741
+3,483
| +5% | +$28.3K |
|
3923
Ponce Financial Group
PDLB
$501M
| $626K | ﹤0.01% |
60,191
+4,448
| +8% | +$43.4K |
|
3924
P3 Health Partners
PIII
$35.8M
| $622K | ﹤0.01% |
1,263
| – | – |
|
3925
US Global Investors
GROW
$38.7M
| $621K | ﹤0.01% |
109,161
+1,724
| +2% | +$10.3K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.